Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Shares Issued (2022 - 2025)

Zentalis Pharmaceuticals (ZNTL) has 4 years of Shares Issued data on record, last reported at $115000.0 in Q3 2025.

  • For Q3 2025, Shares Issued rose 25.0% year-over-year to $115000.0; the TTM value through Sep 2025 reached -$45000.0, down 112.89%, while the annual FY2023 figure was $235.7 million, 8.62% down from the prior year.
  • Shares Issued reached $115000.0 in Q3 2025 per ZNTL's latest filing, down from $189000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $234.4 million in Q3 2023 and bottomed at -$349000.0 in Q4 2024.
  • Average Shares Issued over 4 years is $39.2 million, with a median of $310500.0 recorded in 2023.
  • Peak YoY movement for Shares Issued: plummeted 99.96% in 2024, then rose 25.0% in 2025.
  • A 4-year view of Shares Issued shows it stood at $48.6 million in 2022, then surged by 381.99% to $234.4 million in 2023, then tumbled by 100.15% to -$349000.0 in 2024, then soared by 132.95% to $115000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $115000.0 in Q3 2025, $189000.0 in Q1 2025, and -$349000.0 in Q4 2024.